Beatriz Tavira
Stockholm, AB 14186, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells.
Journal: Cardiovascular diabetology
Published: August 30, 2023
Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells.
Journal: Cardiovascular diabetology
Published: January 24, 2023
Sex-specific regulation of IL-10 production in human adipose tissue in obesity.
Journal: Frontiers in endocrinology
Published: July 18, 2022
Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial).
Journal: Acta diabetologica
Published: October 23, 2021
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes.
Journal: Diabetes/metabolism research and reviews
Published: March 19, 2021
Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients.
Journal: Frontiers in immunology
Published: May 22, 2020
Glutamine Links Obesity to Inflammation in Human White Adipose Tissue.
Journal: Cell metabolism
Published: February 18, 2019
Human-Specific Function of IL-10 in Adipose Tissue Linked to Insulin Resistance.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 09, 2019
Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.
Journal: Journal of diabetes research
Published: January 26, 2018
More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
Journal: The New England journal of medicine
Published: July 27, 2017
Last Updated: 09/26/2026